Is this you? Create Your Porfile
Avatar

Victor H. Engelhard

University of Birmingham

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Victor H. Engelhard is active.

Explore More

Publication

Featured researches published by Victor H. Engelhard.

Archive | 2011

CLASS I MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS

Jeffrey Shabanowitz; Andrew J. Norris; Kara L. Cummings; Victor H. Engelhard; Angela L. Zarling; Rebecca C. Obeng; Jie Qian; Mark Cobbold; Jennifer Cottine; Ann Michelle English; Donald F. Hunt

Archive | 2013

Target peptides for immunotherapy and diagnostics

Donald F. Hunt; Jeffrey Shabanowitz; Stacy A. Malaker; Victor H. Engelhard; Angela L. Zarling; Kara L. Cummings; Rebecca C. Obeng; Mark Cobbold

Archive | 2001

MHC class I associated peptides for prevention and treatment of tuberculosis

David C. Flyer; Mark M. Ross; Donald F. Hunt; Forest M. White; Victor H. Engelhard; Ramila Philip

Archive | 2004

HA-1 epitopes and uses thereof

Els A. J. M. Goulmy; Donald F. Hunt; Victor H. Engelhard

Archive | 2013

This information is current as HLA-A*0201-Transgenic Mice Control of Melanoma Outgrowth in Tyrosinase and Glycoprotein 100 Enable HLA-A*0201-Restricted Epitopes of Immune Responses to the

Valentina Robila; Victor H. Engelhard; David W. Mullins; Timothy Bullock; Teresa A. Colella

Archive | 2013

oncoprotein proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) The minor histocompatibility antigen HA-3 arises from differential

Ferry Ossendorp; Donald F. Hunt; E.A.J.M. Goulmy; Victor H. Engelhard; Jos Pool; Sahana Mollah; Jeffrey Shabanowitz; Laurence C. Eisenlohr; Jennifer A. Caldwell; Suzanne Zegveld; Nia Tatsis; Els Blokland

Archive | 2013

This information is current as by a Novel Mass Spectrometric Technique Cysteinylated Cysteine Residue as Identified Originates from DFFRY and Contains a HY Minor Histocompatibility Antigen Cutting Edge: The HLA-A*0101-Restricted

Victor H. Engelhard; Jeffrey Shabanowitz; Donald F. Hunt; E.A.J.M. Goulmy; Leslie M. Frost; Els Blokland; Carla Reinhardus; Jennifer A. Caldwell; M. White; Jarrod A. Marto; Richard A. Pierce; Erin D. Field; Joke M. M. den Haan

Archive | 2011

Sets Quantitation of Peptides that Constitute Nested Analysis of MHC Class II Antigen Processing by

F. Hunt; Victor H. Engelhard; Timothy Bullock; Jeffrey Shabanowitz; D. Lippolis; M. White; Jarrod A. Marto; J Chance

Archive | 1998

Cystein-reduzierte peptide, welche durch a3-limitierte zytotoxische lymphozyten erkannt werden, sowie anwendungen

Victor H. Engelhard; Donald F. Hunt; David Kittlesen; Craig L. Slingluff

Archive | 1998

Peptides appauvris en cysteine reconnus par des lymphocytes cytotoxiques limites par a3 et leurs mises en application

Craig L. Slingluff; Donald F. Hunt; Victor H. Engelhard; David Kittlesen

Explore More

Collaboration

Dive into the Victor H. Engelhard's collaboration.

Top Co-Authors
Avatar

Donald F. Hunt

Merck KGaA

View shared research outputs
Top Co-Authors
Avatar

Jeffrey Shabanowitz

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Donald F. Hunt

Merck KGaA

View shared research outputs
Top Co-Authors
Avatar

Els A. J. M. Goulmy

University of Virginia

View shared research outputs
Top Co-Authors
Avatar

Angela L. Zarling

University of Missouri

View shared research outputs
Top Co-Authors
Avatar

Craig L. Slingluff

University of Virginia

View shared research outputs
Top Co-Authors
Avatar

David Kittlesen

University of Virginia

View shared research outputs
Top Co-Authors
Avatar

E.A.J.M. Goulmy

Blood bank

View shared research outputs
Top Co-Authors
Avatar

Jarrod A. Marto

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Jennifer A. Caldwell

University of Virginia

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge